IMT-001 (TrueBinding)

N/A

Report date: 2026/01/05 09:51:16

Base Information

Drug NameIMT-001 (TrueBinding)
Drug Alias Nameanti-Gal3 antibody (Immutics)anti-Gal3 antibody (TrueBinding)anti-IMT-L1 antibody (TrueBinding)Gal-3-TIM-3 checkpoint inhibitor (TrueBinding)galectin-3 checkpoint inhibitor (Immutics) +[10] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionGalectin-3 inhibitorsT lymphocytes stimulantsImmunostimulants
TargetsGalectin-3
Therapy Area/IndicationsFibrosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseLung Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrueBinding Inc
China Registration ClassN/A

Develop Information

Active CompaniesTrueBinding Inc
Inactive CompaniesN/A
Active IndicationsFibrosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseLung Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A